Frontiers in Immunology. "Overall, our updated meta-analysis comprising 88 studies suggested that rodents with MS benefited from MSC therapy as manifested by significant amelioration of functional and histopathological [tissue-related] outcomes," the researchers wrote."/> Frontiers in Immunology. "Overall, our updated meta-analysis comprising 88 studies suggested that rodents with MS benefited from MSC therapy as manifested by significant amelioration of functional and histopathological [tissue-related] outcomes," the researchers wrote."/> Study finds MSCs may have therapeutic potential in MS

Study finds MSCs may have therapeutic potential in MS

2021-09-28

A rodent model for multiple sclerosis showed mesenchymal stem cells may help promote the restoration of lost myelin and improve functional abilities, researchers reported in Frontiers in Immunology. "Overall, our updated meta-analysis comprising 88 studies suggested that rodents with MS benefited from MSC therapy as manifested by significant amelioration of functional and histopathological [tissue-related] outcomes," the researchers wrote.

Full story:

SNMMI SmartBrief

Nuclear medicine, molecular imaging and therapy

Designed specifically for nuclear medicine and molecular imaging professionals, SNMMI SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession.